C07F 9/4018
Esters of cycloaliphatic acids
Official title: {Esters of cycloaliphatic acids}
C07F9/4018 (Esters of cycloaliphatic acids) appears on 107 US grants and 26 published applications in this corpus.
Search patents in C07F- Granted patents
- 107
- Published applications
- 26
- Assignees
- 50
- Inventors
- 222
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 5 | 0 |
| 1978 | 9 | 0 |
| 1979 | 4 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 5 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 5 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 3 | 4 |
| 2004 | 3 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 1 | 1 |
| 2008 | 2 | 0 |
| 2009 | 1 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 1 | 3 |
| 2015 | 4 | 3 |
| 2016 | 1 | 1 |
| 2017 | 2 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 3 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for manufacturing alkenyl phosphorus compound7 Apr 2026US 12,595,274 B2Maruzen Petrochemical Co., Ltd.
- Heterocyclic THR-β receptor agonist compound and preparation method and use therefor5 Aug 2025US 12,378,268 B2Hepagene Therapeutics (HK) Limited
- Functionalized naphthalene fluorophores20 Feb 2018US 9,896,479 B2Kay M. Brummond
- Self-assembled monolayers of phosphonic acids as dielectric surfaces for high-performance organic thin film transistors11 Jul 2017US 9,701,698 B2The Chinese University of Hong Kong
- Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase14 Mar 2017US 9,593,136 B2George Mason University
- Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication18 May 2023US 2023/0151034 A1Cocrystal Pharma, Inc.
- Heterocyclic thr-b receptor agonist compound and preparation method and use therefor22 Sep 2022US 2022/0298187 A1Hepagene Therapeutics (HK) Limited
- Method for manufacturing alkenyl phosphorus compound21 Jul 2022US 2022/0227795 A1Maruzen Petrochemical Co., Ltd.
- Esters of non- aromatic heterocyclic compounds having a nematocidal activity, their agronomic compositions and use thereof30 Jun 2022US 2022/0204540 A1Isagro S.p.A.
- Novel polygodial analogs for the treatment of cancer and other proliferative diseases23 Aug 2018US 2018/0237362 A1
Most cited
By later US patents
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method64US 5,962,440 ABristol-Myers Squibb Company · 1999
- Ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists58US 6,710,072 B2Allergan, Inc. · 2004
- 1 And 2-substituted analogues of certain prostaglandins41US 4,171,331 AMiles Laboratories, Inc. · 1979
- Reducing the incidence of gastrointestinal side effects during the treatment of inflammatory conditions with antiinflammatory drugs38US 3,937,801 AAmerican Home Products Corporation · 1976